GMED GenoMed Inc. featured news, full reports, and detailed charts
GenoMed Inc. (GMED/GMED.PK) Wrap Up:
GenoMed, Inc., a development stage biotechnology company, operates in the medical genomics area. The company markets its protocols to prevent kidney failure due to high blood pressure and diabetes, and to delay the progression of emphysema. It also develops treatment products for four diseases, including diabetes, hypertension, emphysema, and psoriasis. GenoMed was formed in 2001 and is based in St. Louis, Missouri.www.genomedics.com
6 Employees
Founded in 2001
GenoMed Inc. (GMED:OTC)
|
Market Cap
808.6K
|
Total Revenue
4.7K
|
|
|
EBITDA
1.1M
|
DILUTED EPS TTM
0.01
|
|
|
P/E
0.7x
|
P/S
170.8x
|
|
|
Return On Asset
65.22
|
Return On Equity
148.43
|
|
| K = Thousands M = Millions B = Billions | ||
GMED Top Compensated Officers
No compensation data is available at this time for the top officers at this company.
Executives, Board Directors
GMED Competitors
| Company | Last | Change | |
| No competitor information is available for GMED. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | GMED | Industry Range |
| Price/Earnings | 0.7x |
|
| Price/Sales | 170.8x |
|
| Price/Book | 28.5x |
|
| Price/Cash Flow | 0.8x |
|
| TEV/Sales | 113.5x |
|
|
GMED |
||
GMED transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About GenoMed Inc.
Would you like to leave a comment about GenoMed Inc. GMED/GMED.PK
Find out what social network information about GenoMed Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides GenoMed Inc. there is more great information available at Realpennies.com